Keyword Connections

hepacivirus / genetics

Journals

0

No Journal Connected

Research Groups

0

No Research Group Connected

Bibliographies

8

1 The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

2 Directly observed therapy of chronic hepatitis C with ledipasvir/sofosbuvir in people who inject drugs at risk of nonadherence to direct-acting antivirals

3 Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis

4 Treatment with direct-acting antiviral agents of hepatitis C virus infection in injecting drug users: A prospective study

5 Acute hepatitis B in patients with or without underlying chronic HCV infection

6 Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosis

7 Effects of sofosbuvir-based treatment, with and without interferon, on outcome and productivity of patients with chronic hepatitis C

8 Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial